HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

Phenomix Sciences Raises $7.8M in...

May 16, 2024

Funding will accelerate the commercialization and adoption of the MyPhenome™ test in the obesity specialist market and the wider industry. The MyPhenome test equips physicians with essential tools to develop effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations reports Phenomix Sciences.

R3 Vascular Announces $87 Million...

May 9, 2024

R3 Vascular will use the proceeds to support the ELITE FDA IDE pivotal trial of its best-in-class bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD.

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

May 16, 2024

Cloud DX Awarded $1.75 Million from NGen Supercluster to Create Advanced Medical Device Centre in Ontario

The Cloud DX Connected Health platform gives doctors the automated monitoring ability they need to send many non-acute patients home sooner, freeing up beds, and relieving pressure on front line staff.

June 23, 2020

Carlsmed Raises $2.5M to Improve Complex Spine Surgery

The round was led by Cove Fund II, a prominent California Life Science and Technology fund. Participating in the round are MedTech funds Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual MedTech investors.

June 23, 2020

Foldax Closes $20 Million Financing

MemorialCare Innovation Fund led the round, with Angel Physicians Fund and Sayan Bioventures joining as new investors.

June 22, 2020

Puzzle Medical Devices Inc. Announces the Closing of a First Financing Round: Funds to Support Clinical Testing of the Transcatheter Pump

"The accomplishments achieved by Puzzle Medical Devices Inc. in such a short period of time are remarkable," stated Pascal Labrecque. "It already has international support from pioneering interventional cardiologists, on top of an ever-growing IP portfolio. We are enthusiastic about its competent team and bright future."

June 15, 2020

GlySens Incorporated Closes Incremental $15 Million Financing

Proceeds from the financing will support ongoing clinical trials and development programs supporting the Company's fully implanted, long-term CGM systems and additionally, enable first-in-man studies of the third-generation system.

June 12, 2020

CytoSorbents Awarded $2,897,172 Phase III STTR Contract

This follows the successful completion of Phase I and II STTR contracts of approximately $1.15 million with researchers at Penn State University, previously funded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) and the U.S. Army Medical Research and Material Command (USAMRMC).

June 9, 2020